Of the 14 million cancer survivors in the United States, a significant number experience a serious side effect called chemotherapy-induced cognitive impairment (CICI). While easily recognized, little is known about the etiology of this condition, also known informally as “chemo brain.” CICI can significantly reduce patients’ quality of life with serious, even devastating, symptoms such as memory lapses, difficulty concentrating, negative impacts on multitasking, confusion and fatigue.
Manasi Malik has just begun her junior year at UK, but the 19-year-old biology major has already been published as a lead author on a paper in a prestigious scientific journal.
The University of Kentucky recently accomplished the “triple crown” of the academic medical world, earning three highly competitive grants and certifications.
